当前位置:首页 - 行情中心 - 迪哲医药-U(688192) - 财务分析 - 现金流量表

迪哲医药-U

(688192)

  

流通市值:245.92亿  总市值:248.03亿
流通股本:4.61亿   总股本:4.65亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金259,026,446.25784,586,671.73559,618,110.76346,296,077.75
  收到其他与经营活动有关的现金10,039,738.6961,540,755.9335,498,609.2535,726,130.67
  经营活动现金流入小计269,066,184.94846,127,427.66595,116,720.01382,022,208.42
  购买商品、接受劳务支付的现金170,800,963.71503,149,726.41365,715,963.02216,360,655.34
  支付给职工以及为职工支付的现金198,307,746.99592,176,224.91434,636,966.7288,977,995.47
  支付的各项税费22,003,278.540,355,616.6513,533,240.174,727,195.75
  支付其他与经营活动有关的现金78,431,826.89298,770,648.26205,287,398.1136,625,730.6
  经营活动现金流出小计469,543,816.091,434,452,216.231,019,173,567.99646,691,577.16
  经营活动产生的现金流量净额-200,477,631.15-588,324,788.57-424,056,847.98-264,669,368.74
二、投资活动产生的现金流量:
  收回投资收到的现金1,896,479,023.29,968,752,061.497,282,902,008.733,631,596,974.15
  处置固定资产、无形资产和其他长期资产收回的现金净额-8,165.198,032.957,607.2
  投资活动现金流入小计1,896,479,023.29,968,760,226.687,282,910,041.683,631,604,581.35
  购建固定资产、无形资产和其他长期资产支付的现金34,913,521.14170,469,026.06149,943,303.92112,832,364.76
  投资支付的现金1,955,000,00010,997,000,0007,585,000,0004,036,000,000
  投资活动现金流出小计1,989,913,521.1411,167,469,026.067,734,943,303.924,148,832,364.76
  投资活动产生的现金流量净额-93,434,497.94-1,198,708,799.38-452,033,262.24-517,227,783.41
三、筹资活动产生的现金流量:
  吸收投资收到的现金-1,776,367,935.511,776,367,935.511,776,367,935.51
  取得借款收到的现金387,080,000810,717,810.54557,217,810.54557,217,810.54
  收到其他与筹资活动有关的现金38,228,080.5317,057,750--
  筹资活动现金流入小计425,308,080.532,604,143,496.052,333,585,746.052,333,585,746.05
  偿还债务支付的现金180,305,800711,907,015.12639,753,685.12524,177,885.12
  分配股利、利润或偿付利息支付的现金7,599,785.9832,891,742.8525,979,444.0918,961,195.24
  支付其他与筹资活动有关的现金11,056,291.8230,659,846.2726,944,199.2414,071,001.34
  筹资活动现金流出小计198,961,877.8775,458,604.24692,677,328.45557,210,081.7
  筹资活动产生的现金流量净额226,346,202.731,828,684,891.811,640,908,417.61,776,375,664.35
四、汇率变动对现金及现金等价物的影响-158,619.01-394,408.41-223,484.38-77,388.63
五、现金及现金等价物净增加额-67,724,545.3741,256,895.45764,594,823994,401,123.57
  加:期初现金及现金等价物余额291,146,638.08249,889,742.63249,889,742.63249,889,742.63
  期末现金及现金等价物余额223,422,092.71291,146,638.081,014,484,565.631,244,290,866.2
补充资料:
  净利润--768,517,444.68--379,042,400.14
  固定资产和投资性房地产折旧-11,960,028.37-3,996,203.15
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-11,960,028.37-3,996,203.15
  无形资产摊销-33,340,462.44-16,792,781.84
  长期待摊费用摊销-7,861,748.29-4,111,508.65
  递延收益摊销----717,522.73
  处置固定资产、无形资产和其他长期资产的损失--279.52--279.52
  公允价值变动损失--25,326,758.27--11,219,000.56
  财务费用-31,610,196.5-17,229,479.65
  存货的减少-7,165,303.32-3,567,558.94
  经营性应收项目的减少--114,025,471.8--16,212,458.58
  经营性应付项目的增加-129,375,305.25-49,664,403.84
  其他-73,647,515.03-34,316,897.32
  现金的期末余额-291,146,638.08-1,244,290,866.2
  减:现金的期初余额-249,889,742.63-249,889,742.63
  现金及现金等价物的净增加额-41,256,895.45-994,401,123.57
公告日期2026-04-302026-03-312025-10-312025-08-23
审计意见(境内)标准无保留意见
TOP↑